262 related articles for article (PubMed ID: 33979194)
1. New Therapies and Biomarkers: Are We Ready for Personalized Treatment in Small Cell Lung Cancer?
Zhang B; Birer SR; Dvorkin M; Shruti J; Byers L
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-10. PubMed ID: 33979194
[TBL] [Abstract][Full Text] [Related]
2. Small cell lung cancer: where do we go from here?
Byers LA; Rudin CM
Cancer; 2015 Mar; 121(5):664-72. PubMed ID: 25336398
[TBL] [Abstract][Full Text] [Related]
3. [Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of
Small Cell Lung Cancer].
Wu Y; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):303-309. PubMed ID: 37183645
[TBL] [Abstract][Full Text] [Related]
4. Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell Lung Cancer (SCLC).
Grenda A; Krawczyk P; Obara A; Gajek Ł; Łomża-Łaba A; Milanowski J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673793
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
[TBL] [Abstract][Full Text] [Related]
6. What Are the Biomarkers for Immunotherapy in SCLC?
Longo V; Catino A; Montrone M; Pizzutilo P; Annese T; Pesola F; Marech I; Cassiano S; Ribatti D; Galetta D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681779
[TBL] [Abstract][Full Text] [Related]
7. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations.
Zhang C; Wang H
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188798. PubMed ID: 36096336
[TBL] [Abstract][Full Text] [Related]
8. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
[TBL] [Abstract][Full Text] [Related]
9. Potential subtype-specific therapeutic approaches in small cell lung cancer.
Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
[TBL] [Abstract][Full Text] [Related]
10. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova EA; Nagel R; Berns A
Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in the treatment of small cell lung cancer.
Hiddinga BI; Raskin J; Janssens A; Pauwels P; Van Meerbeeck JP
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34261744
[TBL] [Abstract][Full Text] [Related]
12. SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K; Kauffmann-Guerrero D; Huber RM
Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
[TBL] [Abstract][Full Text] [Related]
13. Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?
Fasano R; Serratì S; Rafaschieri T; Longo V; Di Fonte R; Porcelli L; Azzariti A
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672414
[TBL] [Abstract][Full Text] [Related]
14. Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports.
Lai L; Meng W; Wei J; Zhang X; Tan Z; Lu Y; Hou E
Medicine (Baltimore); 2021 Mar; 100(10):e25046. PubMed ID: 33725888
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer.
Thai AA; Solomon BJ; Sequist LV; Gainor JF; Heist RS
Lancet; 2021 Aug; 398(10299):535-554. PubMed ID: 34273294
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress of Immunotherapy and Prognostic Markers in Small Cell Lung Cancer].
Wang Q; Peng W; Jiang M; Wu L
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):182-188. PubMed ID: 32102135
[TBL] [Abstract][Full Text] [Related]
17. Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territory.
Kashima J; Okuma Y
Semin Cancer Biol; 2022 Nov; 86(Pt 2):386-395. PubMed ID: 35569741
[TBL] [Abstract][Full Text] [Related]
18. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
Solta A; Ernhofer B; Boettiger K; Megyesfalvi Z; Heeke S; Hoda MA; Lang C; Aigner C; Hirsch FR; Schelch K; Döme B
Mol Cancer; 2024 Feb; 23(1):41. PubMed ID: 38395864
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Treatment Advances in 2022.
Abu Rous F; Singhi EK; Sridhar A; Faisal MS; Desai A
Cancer Invest; 2023 Jan; 41(1):12-24. PubMed ID: 36036470
[TBL] [Abstract][Full Text] [Related]
20. RNA-Seq profiling of circular RNAs in human small cell lung cancer.
Zhang C; Zhang B; Yuan B; Chen C; Zhou Y; Zhang Y; Sheng Z; Sun N; Wu X
Epigenomics; 2020 Apr; 12(8):685-700. PubMed ID: 32079426
[No Abstract] [Full Text] [Related]
[Next] [New Search]